TILT Biotherapeutics

About:

TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor.

Website: http://tiltbio.com/

Top Investors: European Innovation Council, Business Finland, Lifeline Ventures, U.S. Department of Defense, EIC Accelerator

Description:

TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolytic viruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.